Target Name: LOC105376250
NCBI ID: G105376250
Other Name(s): Uncharacterized LOC105376250, transcript variant X2 | LOC105376250 variant X2 | uncharacterized LOC105376250

LOC105376250: A Potential Drug Target and Biomarker

LOC105376250 is a gene that has been identified as a potential drug target or biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. The gene is located on chromosome 10 and has been identified as an exonic splice variant, which means that a specific segment of the gene has been removed or changed, resulting in a different reading frame.

The most well-known variant of LOC105376250 is the transcript variant X2, which has been shown to have a unique expression pattern compared to the wild-type gene. X2 has been shown to have reduced levels of protein expression in various tissues, including the brain, and to have altered gene expression patterns in cancer cells. These findings suggest that X2 may play a role in the development and progression of certain diseases.

In addition to its potential as a drug target, LOC105376250 has also been identified as a potential biomarker for several diseases. For example, studies have shown that LOC105376250 is downregulated in various tissues and organisms that are affected by neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. This suggests that LOC105376250 may be a useful biomarker for these conditions.

Another potential application of LOC105376250 as a drug target is its role in the regulation of inflammation. Several studies have shown that LOC105376250 is involved in the regulation of inflammation and immune responses. For example, studies have shown that LOC105376250 is involved in the regulation of the production of pro-inflammatory cytokines, such as TNF-alpha and IL-12, in macrophages.

In conclusion, LOC105376250 is a gene that has been identified as a potential drug target or biomarker for a variety of diseases. Its unique expression pattern and involvement in the regulation of inflammation make it an attractive candidate for further study. Further research is needed to fully understand the role of LOC105376250 in disease progression and to develop effective treatments.

Protein Name: Uncharacterized LOC105376250

More Common Targets

LOC105376253 | LOC105376270 | LOC105376287 | LOC105376326 | LOC105376344 | LOC105376356 | LOC105376360 | LOC105376361 | LOC105376372 | LOC105376375 | LOC105376387 | LOC105376391 | LOC105376397 | LOC105376400 | LOC105376407 | LOC105376412 | LOC105376413 | LOC105376422 | LOC105376435 | LOC105376440 | LOC105376442 | LOC105376481 | LOC105376482 | LOC105376483 | LOC105376486 | LOC105376502 | LOC105376504 | LOC105376505 | LOC105376512 | LOC105376523 | LOC105376536 | LOC105376548 | LOC105376558 | LOC105376559 | LOC105376566 | LOC105376576 | LOC105376579 | LOC105376583 | LOC105376595 | LOC105376611 | LOC105376622 | LOC105376626 | LOC105376627 | LOC105376645 | LOC105376659 | LOC105376707 | LOC105376732 | LOC105376740 | LOC105376755 | LOC105376767 | LOC105376781 | LOC105376786 | LOC105376805 | LOC105376809 | LOC105376815 | LOC105376817 | LOC105376818 | LOC105376819 | LOC105376823 | LOC105376845 | LOC105376850 | LOC105376885 | LOC105376898 | LOC105376934 | LOC105376981 | LOC105376991 | LOC105377013 | LOC105377016 | LOC105377022 | LOC105377043 | LOC105377046 | LOC105377054 | LOC105377056 | LOC105377095 | LOC105377097 | LOC105377102 | LOC105377103 | LOC105377134 | LOC105377135 | LOC105377136 | LOC105377139 | LOC105377142 | LOC105377149 | LOC105377155 | LOC105377156 | LOC105377166 | LOC105377185 | LOC105377207 | LOC105377253 | LOC105377262 | LOC105377267 | LOC105377272 | LOC105377273 | LOC105377276 | LOC105377280 | LOC105377282 | LOC105377290 | LOC105377294 | LOC105377296 | LOC105377304